Chris Schelling serves as Executive at Acer Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Chris Schelling has executed 4 insider transactions totaling $1.5M, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 17, 2023 involved selling 2,712,529 shares valued at $0.
Chris Schelling currently holds 2,712,529 shares of Acer Therapeutics Inc. (ACER), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Chris Schelling has been a net buyer of ACER stock. They have purchased $1.5M and sold $0 worth of shares.
Chris Schelling's most recent insider trade was on Nov 17, 2023, when they sold 2,712,529 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $1.22 |
| Discretionary |
| Jul 24, 2020 | ACER | $500.0K | Purchase | 142,857 | $3.50 | Discretionary |
| Sep 19, 2017 | ACER | $0 | Other | 1,750,000 | $N/A | Discretionary |